| 产品描述: | Lorglumide sodium salt (CR-1409 sodium salt) 是一种有效的胆囊收缩素(CCK)受体拮抗剂。 |
| 靶点: |
CCK |
| 参考文献: |
1. Scarpignato C, et al. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat. Br J Pharmacol. 1989 Mar;96(3):661-9. |
| 溶解性: |
45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: >10 mg/mL |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.077 ml |
10.387 ml |
20.773 ml |
| 5 mM |
0.415 ml |
2.077 ml |
4.155 ml |
| 10 mM |
0.208 ml |
1.039 ml |
2.077 ml |
| 50 mM |
0.042 ml |
0.208 ml |
0.415 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |